Literature DB >> 33151257

A CHIP in the Armor of Cell-Free DNA-Based Predictive Biomarkers for Prostate Cancer.

Zachery R Reichert1, Morgan A Jones1, Joshi J Alumkal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33151257     DOI： 10.1001/jamaoncol.2020.5140

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  2 in total

1.  Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 Study.

Authors:  Andrea Loehr; Akash Patnaik; David Campbell; Jeremy Shapiro; Alan H Bryce; Ray McDermott; Brieuc Sautois; Nicholas J Vogelzang; Richard M Bambury; Eric Voog; Jingsong Zhang; Josep M Piulats; Arif Hussain; Charles J Ryan; Axel S Merseburger; Gedske Daugaard; Axel Heidenreich; Karim Fizazi; Celestia S Higano; Laurence E Krieger; Cora N Sternberg; Simon P Watkins; Darrin Despain; Andrew D Simmons; Melanie Dowson; Tony Golsorkhi; Simon Chowdhury; Wassim Abida
Journal:  Clin Cancer Res       Date:  2021-10-01       Impact factor: 13.801

2.  What Plasma Can Tell Us When Tissue Cannot: A Case Report of Genomic Testing in mCRPC and Clinical Response to Treatment With the PARP Inhibitor Rucaparib.

Authors:  Daniel P Petrylak; Simon P Watkins; Andrea Loehr
Journal:  Front Oncol       Date:  2022-08-01       Impact factor: 5.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.